Evidence map›Paper›PMID 38632988›Full record

ArticleiScience2024

Bisbiguanide analogs induce mitochondrial stress to inhibit lung cancer cell invasion.

Christina M Knippler, Jamie L Arnst, Isaac E Robinson, Veronika Matsuk, Tala O Khatib, R Donald Harvey, Mala Shanmugam, Janna K Mouw, Haian Fu, Thota Ganesh and 1 more

Open access · goldAbstract read
In one paragraph

Article in iScience, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.6field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Christina M KnipplerDepartment of Hematology and Medical Oncology, Emory University, Atlanta, GA 30322, USA.
Jamie L ArnstWinship Cancer Institute, Emory University, Atlanta, GA 30322, USA.
Isaac E RobinsonDepartment of Hematology and Medical Oncology, Emory University, Atlanta, GA 30322, USA.
Veronika MatsukDepartment of Hematology and Medical Oncology, Emory University, Atlanta, GA 30322, USA.
Tala O KhatibDepartment of Hematology and Medical Oncology, Emory University, Atlanta, GA 30322, USA.
R Donald HarveyDepartment of Hematology and Medical Oncology, Emory University, Atlanta, GA 30322, USA.
Mala ShanmugamDepartment of Hematology and Medical Oncology, Emory University, Atlanta, GA 30322, USA.
Janna K MouwDepartment of Hematology and Medical Oncology, Emory University, Atlanta, GA 30322, USA.
Haian FuDepartment of Hematology and Medical Oncology, Emory University, Atlanta, GA 30322, USA.
Thota GaneshWinship Cancer Institute, Emory University, Atlanta, GA 30322, USA.
Adam I MarcusDepartment of Hematology and Medical Oncology, Emory University, Atlanta, GA 30322, USA.
Emory University · USGeorgia Institute of Technology · US

Funding

Implementing a Maternal health and PRegnancy Outcomes Vision for Everyone (IMPROVE)UL1TR002378 · NCATS · EMORY UNIVERSITY · PI Andres J Garcia, Elizabeth O. Ofili · 2017 to 2026
$92.1M
Winship Cancer Institute Cancer Center Support GrantP30CA138292 · NCI · EMORY UNIVERSITY · PI Ragini Reiney Kudchadkar · 2009 to 2026
$47.5M
Atlanta Clinical and Translational Science Institute (ACTSI) RenewalUL1TR000454 · NCATS · EMORY UNIVERSITY · PI STEPHENS, DAVID S · 2012 to 2016
$25.8M
Project 3: Inhibiting FAK to enhance immune checkpoint inhibitor therapy in LKB1-mutant lung adenocarcinomaP01CA257906 · NCI · EMORY UNIVERSITY · PI Haian Fu · 2022 to 2026
$10.7M
Spatiotemporal interrogation of metabolic cooperation between heterogenous lung cancer subpopulations in collective cell invasionR01CA247367 · NCI · EMORY UNIVERSITY · PI MARCUS, ADAM I., SHANMUGAM, MALATHY (MALA) · 2021 to 2025
$2.3M
T32 CTEng (Cellular and Tissue Engineering) Training ProgramT32GM145735 · NIGMS · GEORGIA INSTITUTE OF TECHNOLOGY · PI Edward A. Botchwey, Andres J Garcia · 2022 to 2026
$2.3M
Atypical Angiogenic Mimicry During Collective Lung Cancer InvasionR01CA236369 · NCI · EMORY UNIVERSITY · PI MARCUS, ADAM I. · 2019 to 2023
$1.8M
Deconstructing the collective invasion pack to define Myo10 functionR01CA250422 · NCI · EMORY UNIVERSITY · PI MARCUS, ADAM I. · 2020 to 2024
$1.8M
Deconstructing cellular heterogeneity and subpopulation cooperation in non-small cell lung cancer metastasisR50CA265345 · NCI · EMORY UNIVERSITY · PI MOUW, JANNA K · 2021 to 2025
$720k
FEI Transmission Electron Microscope with Tomography CapabilityS10RR025679 · NCRR · EMORY UNIVERSITY · PI SPEARMAN, PAUL W. · 2009 to 2009
$500k
Role of phosphate availability in lung cancer invasion and bone metastasisF32CA257436 · NCI · EMORY UNIVERSITY · PI ARNST, JAMIE · 2021 to 2023
$239k
NCATS NIH HHS UL1 TR000454NCATS NIH HHS UL1 TR002378NCI NIH HHS F32 CA257436NCI NIH HHS P01 CA257906NCI NIH HHS P30 CA138292NCI NIH HHS R01 CA236369NCI NIH HHS R01 CA247367NCI NIH HHS R01 CA250422NCI NIH HHS R50 CA265345NCRR NIH HHS S10 RR025679NIGMS NIH HHS T32 GM145735
6 · The paper itself

Abstract

Targeting cancer metabolism to limit cellular energy and metabolite production is an attractive therapeutic approach. Here, we developed analogs of the bisbiguanide, alexidine, to target lung cancer cell metabolism and assess a structure-activity relationship (SAR). The SAR led to the identification of two analogs, AX-4 and AX-7, that limit cell growth via G1/G0 cell-cycle arrest and are tolerated

Indexed as

CancerCell biologyCellular physiology

Identifiers

PMID38632988
PMCPMC11022046
OpenAlexW4393238370

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.